# Clinical Study of Oncolytic Virus in Glioblastoma

> **NCT07145047** · PHASE1,PHASE2 · RECRUITING · sponsor: **Mianyang Central Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Glioblastoma (GBM)

## Interventions

- **BIOLOGICAL:** oncolytic virus

## Key facts

- **NCT ID:** NCT07145047
- **Lead sponsor:** Mianyang Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-02
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145047, "Clinical Study of Oncolytic Virus in Glioblastoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07145047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*